e-learning
resources
Virtual 2020
Pre-Congress Content
Burden and predictive factors for chronic lung diseases and comorbidity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Topical evaluation of growth factors in arterial remodeling in patients with COPD and osteoporosis
L. Ugay (Vladivostok, Russian Federation), E. Kochetkova (Vladivostok, Russian Federation), V. Nevzorova (Vladivostok, Russian Federation), T. Hairzamanova (Vladivostok, Russian Federation)
Source:
Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Session:
Burden and predictive factors for chronic lung diseases and comorbidity
Session type:
E-poster session
Number:
2984
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Ugay (Vladivostok, Russian Federation), E. Kochetkova (Vladivostok, Russian Federation), V. Nevzorova (Vladivostok, Russian Federation), T. Hairzamanova (Vladivostok, Russian Federation). Topical evaluation of growth factors in arterial remodeling in patients with COPD and osteoporosis. 2984
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Smoking induced pulmonary vascular remodelling in patients with mild COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
Source: Eur Respir J 2009; 34: 662
Year: 2009
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018
Is COPD a risk factor for increased arterial stiffness?
Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Year: 2008
Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 342s
Year: 2007
The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Blunted muscle angiogenic training-response in COPD patients versus sedentary controls
Source: Eur Respir J 2013; 41: 806-814
Year: 2013
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
The role of the constitution factors and some blood antigens in the development of osteoporosis in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 324s
Year: 2006
Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013
Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
The role of combination therapy in managing pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 469-475
Year: 2014
Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept